GOIN KATHLEEN (Chief Operating Officer) sold 4.30K shares of PALVELLA THERAPEUTICS, INC. on the open market
Open‑market sale worth $371.0K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/21/2025ACC: 0001104659-25-115017
Officer· Chief Operating Officer
Since Feb 2026
-4.30K
Net shares
Net seller
$371.0K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
4.30K acquired · 8.60K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+2.15K
Price / share
$7.14
Trade value
$15.38K
% of position
New position
11/19/2025
0.00→2.15K
Common Stock
Direct
Shares
+2.15K
Price / share
$9.08
Trade value
$19.50K
% of position
99.7%
11/19/2025
2.15K→4.30K
Common Stock
Direct
Shares
−1.50K
Price / share
$85.72
Trade value
$128.58K
% of position
34.9%
11/19/2025
4.30K→2.80K
Common Stock
Direct
Shares
−2.80K
Price / share
$86.51
Trade value
$242.39K
% of position
New position
11/19/2025
2.80K→0.00
Total
Net shares
+0.00
Net value
-$336.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/19/2025 | M · Option Exercise | +2.15K | $7.14 | $15.38K | New position | 0.00 | 2.15K |
| Common Stock Direct | 11/19/2025 | M · Option Exercise | +2.15K | $9.08 | $19.50K | 99.7% | 2.15K | 4.30K |
| Common Stock Direct | 11/19/2025 | S · Sale | −1.50K | $85.72 | $128.58K | 34.9% | 4.30K | 2.80K |
| Common Stock Direct | 11/19/2025 | S · Sale | −2.80K | $86.51 | $242.39K | New position | 2.80K | 0.00 |
| Total | +0.00 | -$336.08K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.15K shares
Shares
−2.15K
Strike price
7.14
Held after
23.70K
Exercisable
—
11/19/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.15K shares
Shares
−2.15K
Strike price
9.08
Held after
23.63K
Exercisable
—
11/19/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.15K shares | 11/19/2025 | M · Option Exercise | −2.15K | 7.14 | — | 23.70K |
| Stock Option (Right to Buy) Direct | Common Stock2.15K shares | 11/19/2025 | M · Option Exercise | −2.15K | 9.08 | — | 23.63K |